CAMBRIDGE, UK, 02 July 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it had been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University. Evonetix is revolutionising gene synthesis with the aim of producing DNA at scale to facilitate many applications in the rapidly growing field of…

Attributes ongoing success to scientific ethos, project management, and innovative research programs.Cambridge, UK, 02 July 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, is celebrating its fifth anniversary. To mark the occasion, the Company held an anniversary party at King’s College, Cambridge, on 30th June 2018, with drinks, dinner and live music.  The Company was founded, without external investment, in 2013, by Dr John McCafferty, now CEO at IONTAS, in his laboratories within the biochemistry department of the University of…

NESDEP portable laboratory for pathogen detection is now being transferred for manufacture NESDEP detects pathogens in less than 90 minutes, and aims to provide significant cost savings whilst reducing the incidence of foodborne illnesses Cambridge, UK, 02 July 2018: TTP Plc (TTP), a leading independent technology and product development company, and Cubed Laboratories (Cubed), a developer of rapid, DNA-based molecular diagnostic devices and test kits, today announced the successful completion of a project to develop Cubed’s core product, the NESDEP portable laboratory for pathogen…